0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À¯¹æ¾Ï ȯÀÚÀÇ ÀÚ°¡°ü¸®¿¡ ´ëÇÑ ÀÚ±âÈ¿´É°¨ ÃøÁ¤µµ±¸ °³¹ß

Development and Validation of Self-Efficacy Scale for Self-Management of Breast Cancer (SESSM-B)

Journal of Korean Academy of Nursing 2012³â 42±Ç 3È£ p.385 ~ 395
KMID : 0806120120420030385
À̶õ ( Lee Ran ) - ±¹¸³¾Ï¼¾ÅÍ ³»½Ã°æ½Ç ¼ö°£È£»ç

±è¼öÇö ( Kim Soo-Hyun ) - ÀÎÇÏ´ëÇб³ °£È£Çаú Á¶±³¼ö
À̰Ǽ÷ ( Lee Keon-Sook ) - ±¹¸³¾Ï¼¾ÅÍ À¯¹æ¾Ï¼¾ÅÍ ¼ö°£È£»ç
¼­¸í°æ ( Seo Myung-Kyung ) - ±¹¸³¾Ï¼¾ÅÍ À¯¹æ¾Ï¼¾ÅÍ °£È£»ç

Abstract

Purpose: This purpose of this study was to develop and validate a Self-Efficacy Scale for Self-Management of Breast Cancer (SESSM-B).

Methods: The SESSM-B was developed and validated as follows: Item generation, pilot study, and tests of validity and reliability. Twenty-one items were developed through evaluation by 10 experts and 13 items were finally confirmed through item analysis and factor analysis. Psychometric testing was performed with a convenience sample of 303 women with breast cancer. Data were analyzed using factor analysis, Pearson correlation coefficients, and Cronbach¡¯s alpha.

Results: Five factors evolved from the factor analysis, which explained 69.8% of the total variance. The first factor ¡¯coping with psycho-informational demand¡¯ explained 17.2%, 2nd factor ¡¯maintenance of healthy lifestyle¡¯ 14.5%. 3rd factor ¡¯management of side-effects¡¯ 13.3%, 4th factor ¡¯therapeutic compliance¡¯ 12.8%, and 5th factor ¡¯sexual life¡¯ 11.9%. SESSM-B also demonstrated a concurrent validity with health-related quality of life scale, EORTC QLQ-C30 & BR23. The internal consistency, Cronbach¡¯s alpha, was .78, and reliability of the subscales ranged from .61 to .79.

Conclusion: The results of this study suggest that the SESSM-B is an easy, reliable, and valid instrument to measure self-efficacy for self-management of breast cancer.
KeyWords

Breast cancer, Self-efficacy, Validation studies
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed